Refinement of diagnosis and disease classification in psychiatry

European Archives of Psychiatry and Clinical Neuroscience

Volumn 258, Issue SUPPL. 1, 2008, Pages 6-11

  Lecrubier, Yves ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Classification; Diagnosis; DSM; ICD; Psychiatry

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT;

CONFERENCE PAPER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EATING DISORDER; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; HEREDITY; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SYMPTOMATOLOGY;

HUMANS; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHIATRY; PSYCHOTROPIC DRUGS; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 41049103104     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-007-1003-0     Document Type: Conference Paper

References (47)

1. APA (1994) Diagnostic and statistical manual of mental disorders DSM-IV. American Psychiatric Association, Washington
2. APA (2000) Diagnostic criteria from DSM-IV-TR. American Psychiatric Association, Washington
3. Balázs J, Bitter I, Lecrubier Y, Csiszér N, Ostorharics G (2000) Prevalence of subthreshold forms of psychiatric disorders in persons making suicide attempts in Hungary. Eur Psychiatry 15(6):354-361
4. Cannon M, Jones PB, Murray RM (2002) Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 159:1080-1092
5. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002) A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159(4):539-545
6. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301(5631):386-389
7. Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57(10):1117-1127
8. First MB (2005) Mutually Exclusive versus co-occuring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology 38(4):206-210
9. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H (2004) Modulation of cortical-limbic pathways in major depression. Treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61(1):34-41
10. Gould TD, Gottesman II (2006) Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5(2):113-9
11. Harvey PD, Keefe RS (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am J Psychiatry 158(2):176-184
12. Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW (2006) Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch Gen Psychiatry 63(3):298-304
13. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50(2-3):97-108
14. Kapur S, Mizrahi R, Li M (2005) From dopamine to salience to psychosis-linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79(1):59-68
15. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49(4):603-615
16. Kendler KS (2006) Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry 163(7):1138-1146
17. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry 51:8-19
18. Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US national comorbidity survey. Br J Psychiatry 168(30):17-30
19. Kirkpatrick B, Fenton WS, Carpenter WT, Marder SR (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 32(2):214-219
20. Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P (2001) Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 103(5):323-334
21. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17):9235-9240
22. Lecrubier Y (2001) The influence of comorbidity on the prevalence of suicidal behavior. Eur Psychiatry 16:395-399
23. Lecrubier Y (1993) The importance of national therapeutic strategies for the treatment of subthreshold depressive disorders. Eur Psychiatry 8(5):233-234
24. Lecrubier Y, Sheehan DV, Weiller E, Armorin P, Bonara I, Sheehan KH, Janavs J, Dunbar GC (1997) The mini international neuropsychiatric interview (MINI) a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 12(5):224-231
25. MATRICS, available at http://www.matrics.ucla.edu
26. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45:651-660
27. Mc Gurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schizophr Res 45(3):175-184
28. Melle I, Larsen TK, Haahr U, Friis S, Johannessen JO, Opjordsmoen S, Simonsen E, Rund BR, Vaglum P, McGlashan T (2004) Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 61(2):143-150
29. Meltzer HY, McGurk SR (1999) The effects of clozapine, ripseridone and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25(2):233-255
30. Montgomery SA, Van Zwieten-Boot B (2007) ECNP consensus meeting. Negative, depressive and cognitive symptoms of schizophrenia. Nice, March 2004. Eur Neuropsychopharmacol 17:70-77
31. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291-297
32. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A (1995) Residual symptoms after partial remission: an important outcome in depression. Psychol Med 25(6):1171-1180
33. Pedersen CB, Mortensen PB (2001) Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 58(11):1039-1046
34. Phillips KA, Kaye WH (2007) The relationship of body dysmorphic disorder and eating disorders to obsessive-compulsive disorder. CNS Spectr 12(5):347-358
35. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF (1998) Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 173(34):24-28
36. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M (2004) Cognitive enhancers as adjuncts to psychotherapy: use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 61(11):1136-1144
37. Rickels K, Downing R, Schweizer R, Hassman H (1993) Antidepressants for the treatment of imipramine, trazodone and diazepam. Arch Gen Psychiatry 50:884-895
38. Robins LN, Wing J, Wittchen H-U, Helzer JE (1988) The composite international diagnostic interview: an epidemiological instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 45:1069-1077
39. Size and burden of mental disorders in Europe (2005) European Neuropsychopharmacology 15(4):355-490
40. Selten JP, Cantor-Graae E (2005) Social defeat: risk factor for schizophrenia? Br J Psychiatry 187:101-102
41. Seminowicz DA, Mayberg HS, McIntosh AR, Goldapple K, Kennedy S, Segal Z, Rafi-Tari S (2004) Limbic-frontal circuitry in major depression: a path modelling metanalysis. Neuroimage 22:409-418
42. Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC (1997) Reliability and validity of the mini international neuropsychiatric interview (MINI) according to SCID-P. Eur Psychiatry 12(5):232-241
43. Watson D (2005) Rethinking the mood and anxiety disorders; a quantitative hierarchical model for DSM-V. J Abnorm Psychol 114(4):522-536
44. Wittchen H-U, Beesdo K, Bittner A, Goodwin RD (2003) Depressive episodes-evidence for a causal role of primary anxiety disorders? Eur Psychiatry 18:384-393
45. Wolf DH (2006) Anhedonia in Schizophrenia. Curr Psychiatry Rep 8:322-328
46. Woods SW, Breier A, Zipursky RB, Perkins DO, Addington J, Miller TJ, Hawkins KA, Marquez E, Lindborg SR, Tohen M, McGlashan TH (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol Psychiatry 54(4):453-464
47. World Health Organisation (1993) The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for research. World Health Organisation, Geneva, Swizerland